Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Congestive heart failure (CHF) is a physiological condition that has an adverse impact on the pumping efficiency of the cardiac muscles. It characterizes the accumulation of fluid around the heart leading to inefficient pumping. The onset of CHF is marked by the failure of the ventricles to pump sufficient volume of blood to the body organs. This eventually leads to deposition of fluid in the lungs, abdomen, liver, and lower body. CHF is treated by a number of devices that maintain heart rhythm, such as pacemakers, cardiac resynchronization therapy (CRT), implantable cardioverter defibrillators (ICDs), and ventricular assist devices (VADs).
This is primarily attributed to the constantly changing lifestyle habits (such as unhealthy dietary habits, excessive alcohol consumption, smoking, obesity, and lack of physical activity) which make individuals more susceptible to arrhythmia and heart failure. In addition, a number of factors such as the large number of technological advancements in CHF treatment devices, increased adoption rate of these devices, and rising emphasis on early intervention and primary prevention of heart-related disorders are responsible for driving the market. Conversely, stringent government regulations for the approval of CHF treatment devices, high cost of, and high preference to drugs for CHF treatment are some of the factors restraining the market growth.
The report details the trend, potential and market size of Congestive Heart Failure (CHF) Treatment Devices market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Congestive Heart Failure (CHF) Treatment Devicesmarket, defines the market attractiveness level of Congestive Heart Failure (CHF) Treatment Devices market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Congestive Heart Failure (CHF) Treatment Devices industry, describes the types of Congestive Heart Failure (CHF) Treatment Devices market, the applications of major players and the market size, and deeply analyzes the current situation of the global Congestive Heart Failure (CHF) Treatment Devices market and the development prospects and opportunities of Congestive Heart Failure (CHF) Treatment Devices industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Congestive Heart Failure (CHF) Treatment Devices market in Chapter 13.
By Player:
LivaNova PLC
Biotronik SE & Co KG
Berlin Heart GmbH
Jarvik Heart
HeartWare International
ReliantHeart
Boston Scientific Corporation
Abiomed
St Jude Medical
Medtronic
By Type:
Cardiac Resynchronization Therapy (CRT)
Implantable Cardioverter Defibrillators (ICDs)
By End-User:
Left Ventricular Assist Device (LVAD)
Right Ventricular Assist Device (RVAD)
Biventricular Assist Device (BIVAD)
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Congestive Heart Failure (CHF) Treatment Devices Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Congestive Heart Failure (CHF) Treatment Devices Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Congestive Heart Failure (CHF) Treatment Devices Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Congestive Heart Failure (CHF) Treatment Devices Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Congestive Heart Failure (CHF) Treatment Devices Market Analysis and Outlook to 2022
-
7.1 Global Congestive Heart Failure (CHF) Treatment Devices Consumption (2017-2022)
-
7.2 United States Congestive Heart Failure (CHF) Treatment Devices Consumption (2017-2022)
-
7.3 Europe Congestive Heart Failure (CHF) Treatment Devices Consumption (2017-2022)
-
7.4 China Congestive Heart Failure (CHF) Treatment Devices Consumption (2017-2022)
-
7.5 Japan Congestive Heart Failure (CHF) Treatment Devices Consumption (2017-2022)
-
7.6 India Congestive Heart Failure (CHF) Treatment Devices Consumption (2017-2022)
-
7.7 South Korea Congestive Heart Failure (CHF) Treatment Devices Consumption (2017-2022)
8 Region and Country-wise Congestive Heart Failure (CHF) Treatment Devices Market Analysis and Outlook to 2028
-
8.1 Global Congestive Heart Failure (CHF) Treatment Devices Consumption Forecast (2022-2028)
-
8.2 United States Congestive Heart Failure (CHF) Treatment Devices Consumption Forecast (2022-2028)
-
8.3 Europe Congestive Heart Failure (CHF) Treatment Devices Consumption Forecast (2022-2028)
-
8.4 China Congestive Heart Failure (CHF) Treatment Devices Consumption Forecast (2022-2028)
-
8.5 Japan Congestive Heart Failure (CHF) Treatment Devices Consumption Forecast (2022-2028)
-
8.6 India Congestive Heart Failure (CHF) Treatment Devices Consumption Forecast (2022-2028)
-
8.7 South Korea Congestive Heart Failure (CHF) Treatment Devices Consumption Forecast (2022-2028)
9 Global Congestive Heart Failure (CHF) Treatment Devices Market Outlook by Types and Applications to 2022
-
9.1 Global Congestive Heart Failure (CHF) Treatment Devices Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Cardiac Resynchronization Therapy (CRT) Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Implantable Cardioverter Defibrillators (ICDs) Consumption and Growth Rate (2017-2022)
-
9.2 Global Congestive Heart Failure (CHF) Treatment Devices Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Left Ventricular Assist Device (LVAD) Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Right Ventricular Assist Device (RVAD) Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Biventricular Assist Device (BIVAD) Consumption and Growth Rate (2017-2022)
10 Global Congestive Heart Failure (CHF) Treatment Devices Market Outlook by Types and Applications to 2028
-
10.1 Global Congestive Heart Failure (CHF) Treatment Devices Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Cardiac Resynchronization Therapy (CRT) Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Implantable Cardioverter Defibrillators (ICDs) Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Congestive Heart Failure (CHF) Treatment Devices Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Left Ventricular Assist Device (LVAD) Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Right Ventricular Assist Device (RVAD) Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Biventricular Assist Device (BIVAD) Consumption Forecast and Growth Rate (2022-2028)
11 Global Congestive Heart Failure (CHF) Treatment Devices Import and Export Analysis (Top 5 Countries)
-
11.1 Global Congestive Heart Failure (CHF) Treatment Devices Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Congestive Heart Failure (CHF) Treatment Devices Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Congestive Heart Failure (CHF) Treatment Devices Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Congestive Heart Failure (CHF) Treatment Devices Market Competitive Analysis
-
14.1 LivaNova PLC
-
14.1.1 LivaNova PLC Company Details
-
14.1.2 LivaNova PLC Congestive Heart Failure (CHF) Treatment Devices Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 LivaNova PLC Congestive Heart Failure (CHF) Treatment Devices Product and Service
-
14.2 Biotronik SE & Co KG
-
14.2.1 Biotronik SE & Co KG Company Details
-
14.2.2 Biotronik SE & Co KG Congestive Heart Failure (CHF) Treatment Devices Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Biotronik SE & Co KG Congestive Heart Failure (CHF) Treatment Devices Product and Service
-
14.3 Berlin Heart GmbH
-
14.3.1 Berlin Heart GmbH Company Details
-
14.3.2 Berlin Heart GmbH Congestive Heart Failure (CHF) Treatment Devices Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Berlin Heart GmbH Congestive Heart Failure (CHF) Treatment Devices Product and Service
-
14.4 Jarvik Heart
-
14.4.1 Jarvik Heart Company Details
-
14.4.2 Jarvik Heart Congestive Heart Failure (CHF) Treatment Devices Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Jarvik Heart Congestive Heart Failure (CHF) Treatment Devices Product and Service
-
14.5 HeartWare International
-
14.5.1 HeartWare International Company Details
-
14.5.2 HeartWare International Congestive Heart Failure (CHF) Treatment Devices Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 HeartWare International Congestive Heart Failure (CHF) Treatment Devices Product and Service
-
14.6 ReliantHeart
-
14.6.1 ReliantHeart Company Details
-
14.6.2 ReliantHeart Congestive Heart Failure (CHF) Treatment Devices Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 ReliantHeart Congestive Heart Failure (CHF) Treatment Devices Product and Service
-
14.7 Boston Scientific Corporation
-
14.7.1 Boston Scientific Corporation Company Details
-
14.7.2 Boston Scientific Corporation Congestive Heart Failure (CHF) Treatment Devices Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Boston Scientific Corporation Congestive Heart Failure (CHF) Treatment Devices Product and Service
-
14.8 Abiomed
-
14.8.1 Abiomed Company Details
-
14.8.2 Abiomed Congestive Heart Failure (CHF) Treatment Devices Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Abiomed Congestive Heart Failure (CHF) Treatment Devices Product and Service
-
14.9 St Jude Medical
-
14.9.1 St Jude Medical Company Details
-
14.9.2 St Jude Medical Congestive Heart Failure (CHF) Treatment Devices Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 St Jude Medical Congestive Heart Failure (CHF) Treatment Devices Product and Service
-
14.10 Medtronic
-
14.10.1 Medtronic Company Details
-
14.10.2 Medtronic Congestive Heart Failure (CHF) Treatment Devices Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Medtronic Congestive Heart Failure (CHF) Treatment Devices Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Congestive Heart Failure (CHF) Treatment Devices
-
Figure Congestive Heart Failure (CHF) Treatment Devices Picture
-
Table Global Congestive Heart Failure (CHF) Treatment Devices Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Congestive Heart Failure (CHF) Treatment Devices Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Congestive Heart Failure (CHF) Treatment Devices Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Congestive Heart Failure (CHF) Treatment Devices Consumption by Country (2017-2022)
-
Figure United States Congestive Heart Failure (CHF) Treatment Devices Consumption and Growth Rate (2017-2022)
-
Table Europe Congestive Heart Failure (CHF) Treatment Devices Consumption and Growth Rate (2017-2022)
-
Figure China Congestive Heart Failure (CHF) Treatment Devices Consumption and Growth Rate (2017-2022)
-
Figure Japan Congestive Heart Failure (CHF) Treatment Devices Consumption and Growth Rate (2017-2022)
-
Figure India Congestive Heart Failure (CHF) Treatment Devices Consumption and Growth Rate (2017-2022)
-
Figure South Korea Congestive Heart Failure (CHF) Treatment Devices Consumption and Growth Rate (2017-2022)
-
Figure Global Congestive Heart Failure (CHF) Treatment Devices Consumption Forecast by Country (2022-2028)
-
Figure United States Congestive Heart Failure (CHF) Treatment Devices Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Congestive Heart Failure (CHF) Treatment Devices Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Congestive Heart Failure (CHF) Treatment Devices Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Congestive Heart Failure (CHF) Treatment Devices Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Congestive Heart Failure (CHF) Treatment Devices Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Congestive Heart Failure (CHF) Treatment Devices Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cardiac Resynchronization Therapy (CRT) Consumption and Growth Rate (2017-2022)
-
Figure Global Implantable Cardioverter Defibrillators (ICDs) Consumption and Growth Rate (2017-2022)
-
Figure Global Left Ventricular Assist Device (LVAD) Consumption and Growth Rate (2017-2022)
-
Figure Global Right Ventricular Assist Device (RVAD) Consumption and Growth Rate (2017-2022)
-
Figure Global Biventricular Assist Device (BIVAD) Consumption and Growth Rate (2017-2022)
-
Figure Global Cardiac Resynchronization Therapy (CRT) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Implantable Cardioverter Defibrillators (ICDs) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Left Ventricular Assist Device (LVAD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Right Ventricular Assist Device (RVAD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Biventricular Assist Device (BIVAD) Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Congestive Heart Failure (CHF) Treatment Devices Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Congestive Heart Failure (CHF) Treatment Devices Export by Region (Top 5 Countries) (2017-2028)
-
Table LivaNova PLC (Foundation Year, Company Profile and etc.)
-
Table LivaNova PLC Congestive Heart Failure (CHF) Treatment Devices Sales, Price, Value and Gross Profit (2017-2022)
-
Table LivaNova PLC Congestive Heart Failure (CHF) Treatment Devices Product and Service
-
Table Biotronik SE & Co KG (Foundation Year, Company Profile and etc.)
-
Table Biotronik SE & Co KG Congestive Heart Failure (CHF) Treatment Devices Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biotronik SE & Co KG Congestive Heart Failure (CHF) Treatment Devices Product and Service
-
Table Berlin Heart GmbH (Foundation Year, Company Profile and etc.)
-
Table Berlin Heart GmbH Congestive Heart Failure (CHF) Treatment Devices Sales, Price, Value and Gross Profit (2017-2022)
-
Table Berlin Heart GmbH Congestive Heart Failure (CHF) Treatment Devices Product and Service
-
Table Jarvik Heart (Foundation Year, Company Profile and etc.)
-
Table Jarvik Heart Congestive Heart Failure (CHF) Treatment Devices Sales, Price, Value and Gross Profit (2017-2022)
-
Table Jarvik Heart Congestive Heart Failure (CHF) Treatment Devices Product and Service
-
Table HeartWare International (Foundation Year, Company Profile and etc.)
-
Table HeartWare International Congestive Heart Failure (CHF) Treatment Devices Sales, Price, Value and Gross Profit (2017-2022)
-
Table HeartWare International Congestive Heart Failure (CHF) Treatment Devices Product and Service
-
Table ReliantHeart (Foundation Year, Company Profile and etc.)
-
Table ReliantHeart Congestive Heart Failure (CHF) Treatment Devices Sales, Price, Value and Gross Profit (2017-2022)
-
Table ReliantHeart Congestive Heart Failure (CHF) Treatment Devices Product and Service
-
Table Boston Scientific Corporation (Foundation Year, Company Profile and etc.)
-
Table Boston Scientific Corporation Congestive Heart Failure (CHF) Treatment Devices Sales, Price, Value and Gross Profit (2017-2022)
-
Table Boston Scientific Corporation Congestive Heart Failure (CHF) Treatment Devices Product and Service
-
Table Abiomed (Foundation Year, Company Profile and etc.)
-
Table Abiomed Congestive Heart Failure (CHF) Treatment Devices Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abiomed Congestive Heart Failure (CHF) Treatment Devices Product and Service
-
Table St Jude Medical (Foundation Year, Company Profile and etc.)
-
Table St Jude Medical Congestive Heart Failure (CHF) Treatment Devices Sales, Price, Value and Gross Profit (2017-2022)
-
Table St Jude Medical Congestive Heart Failure (CHF) Treatment Devices Product and Service
-
Table Medtronic (Foundation Year, Company Profile and etc.)
-
Table Medtronic Congestive Heart Failure (CHF) Treatment Devices Sales, Price, Value and Gross Profit (2017-2022)
-
Table Medtronic Congestive Heart Failure (CHF) Treatment Devices Product and Service
-
